BRIEF RESEARCH REPORT
Published on 20 Jul 2023
Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study
![Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study](https://www.frontiersin.org/files/myhome article library/1165106/1165106_Thumb_400.jpg)
doi 10.3389/fimmu.2023.1165106
- 2,013 views
- 4 citations